Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis

被引:253
|
作者
Lehrke, Michael [1 ]
Becker, Alexander [2 ]
Greif, Martin [2 ]
Stark, Renee [3 ]
Laubender, Ruediger P. [4 ]
von Ziegler, Franz [2 ]
Lebherz, Corinna [2 ]
Tittus, Janine [2 ]
Reiser, Maximilian [5 ]
Becker, Christoph [5 ]
Goeke, Burkhard [1 ]
Leber, Alexander W. [2 ]
Parhofer, Klaus G. [1 ]
Broedl, Uli C. [1 ]
机构
[1] Univ Munich, Dept Internal Med 2, D-81377 Munich, Germany
[2] Univ Munich, Dept Internal Med 1, D-81377 Munich, Germany
[3] Helmholtz Zentrum, Munich, Germany
[4] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany
[5] Univ Munich, Dept Radiol, Munich, Germany
关键词
ADIPOKINE; ADIPOCYTE;
D O I
10.1530/EJE-09-0380
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Chemerin is a recently discovered adipokine that regulates adipocyte differentiation and modulates chemotaxis and activation of dendritic cells and macrophages. Given the convergence of adipocyte and macrophage function, chemerin may provide an interesting link between obesity. inflammation and atherosclerosis in humans. We sought to examine the relationship of i) chemerin and markers of inflammation, ii) chemerin and components of the metabolic syndrome. and iii) chemerin and coronary atherosclerotic plaque burden and morphology. Design: Serum chemerin levels were determined in 303 patients with stable typical or atypical chest Pain Who Underwent dual-source multi-slice CT-angiography to exclude coronary artery stenosis. Atherosclerotic plaques were classified its calcified, mixed. or non-calcified. Results: Chemerin levels were highly correlated with high sensitivity C-reactive protein (r=0.44. P<0.0001). interleukin-6 (r=0.18, P=0.002), tumor necrosis factor-alpha. (r=0.24, P<0.0001). resistin (r=0.28. P<0.0001), and leptin r=0.36. P<0.0001) concentrations. Furthermore, chemerin was associated with components of the metabolic syndrome including body mass index (r=0.23, P=0.0002). triglycerides (r=0.29. P<0.0001), HDL-cholesterol (r=-0.18, P=0.003). and hypertension (P<0.0001). In bivariate analysis. chemerin levels were weakly correlated with coronary plaque burden (r=0.16. P=0.006) and the number of non-calcified plaques (r=0.14. P=0.02). These associations, however, were lost after adjusting for established cardiovascular risk factors (odds ratio. OR 1.17, 95%, confidence interval (Cl) 0.97-1.41. P=0.11 for coronary plaque burden: OR 1.06, 95% Cl 0.96-1.17. P=0.22 for non-calcified plaques). Conclusions: Chemerin is strongly associated with markers of inflammation and components of the metabolic syndrome. However, chemerin does not predict coronary, atherosclerosis.
引用
收藏
页码:339 / 344
页数:6
相关论文
共 50 条
  • [1] Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis
    Broedl, U. C.
    Lehrke, M.
    Becker, A.
    Greif, M.
    Stark, R.
    Laubender, R. P.
    von Ziegler, F.
    Lebherz, C.
    Tittus, J.
    Reiser, M.
    Becker, C.
    Goeke, B.
    Leber, A. W.
    Parhofer, K. G.
    DIABETOLOGIA, 2009, 52 : S514 - S514
  • [2] ELECTROCARDIOGRAPHIC MARKERS ASSOCIATED WITH MYOCARDIUM METABOLIC CHANGES, THEIR RELATIONSHIP WITH COMPONENTS OF METABOLIC SYNDROME IN CORONARY ATHEROSCLEROSIS
    Ragino, Y.
    Timoshenko, N.
    Chernjavskiy, A.
    Kamenskaja, O.
    Voevoda, M.
    ATHEROSCLEROSIS, 2015, 241 (01) : E172 - E172
  • [3] Atherosclerosis and markers of inflammation in patients with metabolic syndrome
    Novo, G
    Corrado, E
    Muratori, I
    Bellia, A
    Galluzzo, A
    Bonura, F
    Vitale, G
    Novo, S
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 201A - 202A
  • [4] Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis
    Coutinho, Thais de A.
    Turner, Stephen T.
    Peyser, Patricia A.
    Bielak, Lawrence F.
    Sheedy, Patrick F., II
    Kullo, Iftikhar J.
    AMERICAN JOURNAL OF HYPERTENSION, 2007, 20 (01) : 83 - 89
  • [5] ROLES OF THE METABOLIC SYNDROME AND CORONARY ATHEROSCLEROSIS IN SUBCLINICAL INFLAMMATION
    Rein, P.
    Saely, C. H.
    Beer, S.
    Vonbank, A.
    Drexel, H.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 32 - 32
  • [6] Ventricular arrhythmogenicity is associated with markers of atherosclerosis and low-grade inflammation in the metabolic syndrome
    Voulgari, Christina
    Tentolouris, Nicholas
    Moyssakis, Ioannis
    Papadogiannis, Dimitrios
    Dilaveris, Polychronis
    Perrea, Despoina
    Makrilakis, Konstantinos
    Stefanadis, Christodoulos
    Katsilambros, Nicholas
    DIABETES, 2008, 57 : A628 - A629
  • [7] Indicators associated with coronary atherosclerosis in metabolic syndrome
    Chiu, Ting-Yu
    Chen, Ching-Yuan
    Chen, Shan-Yin
    Soon, Chang-Chieng
    Chen, Jaw-Wen
    CLINICA CHIMICA ACTA, 2012, 413 (1-2) : 226 - 231
  • [8] Chemerin is associated with inflammatory markers and metabolic syndrome phenotypes in hypertension patients
    Gu, Ping
    Jiang, Weimin
    Lu, Bin
    Shi, Zhaorong
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2014, 36 (05) : 326 - 332
  • [9] Does metabolic syndrome predict progression of calcified coronary atherosclerosis? the relationship between the 'Metabolic score' and coronary artery calcium progression
    Taylor, Allen J.
    Wu, Hongyan
    Bindeman, Jody
    Byrd, Carole
    Bauer, Kelly
    O'Malley, Patrick G.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 397A - 397A
  • [10] PLASMA CHEMERIN IS ASSOCIATED WITH MARKERS OF INFLAMMATION AND CORONARY ARTERY DISEASE IN PATIENTS NOT ON ASPIRIN
    Herova, M.
    Schmid, M.
    Hersberger, M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 87 - 87